首页> 外国专利> Polyvalent T. at least against diphtheria, gray myelitis and tetanus. D. Polio vaccine

Polyvalent T. at least against diphtheria, gray myelitis and tetanus. D. Polio vaccine

机译:多价T.至少抗白喉,灰色脊髓炎和破伤风。 D.脊髓灰质炎疫苗

摘要

Vaccine formulated for exclusive use as a repeat ('booster') vaccine in a population already having received a primary vaccine and/or sensitized against at least the poliovirus, Corynebacterium diphteriae and/or C. tetani, is new. Vaccine (I) formulated for exclusive use as a repeat ('booster') vaccine in a population already having received a primary vaccine and/or sensitized against at least the poliovirus, Corynebacterium diphteriae and/or C. tetani, comprises, (1) at least 1.2 mg/ml of aluminum sa (2) antigens derived from at least the poliovirus; and (3) a quantity of diphtheria anatoxin (DA) used as an antigen of C. diphteriae comprising between 4-16 Flocculation units (Fu);
机译:在已经接受过一级疫苗和/或至少对脊髓灰质炎病毒,双歧杆菌和/或破伤风梭菌致敏的人群中,配制为重复(“加强”)疫苗专用的疫苗是新的。配制为在已经接种过一级疫苗和/或至少对脊髓灰质炎病毒,双歧杆菌和/或破伤风梭菌致敏的人群中专门用作重复疫苗的疫苗(I),包括(1)至少1.2 mg / ml铝盐; (2)至少来自脊髓灰质炎病毒的抗原; (3)用作白喉衣原体抗原的白喉抗毒素(DA)的数量包括4-16个絮凝单位(Fu);

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号